Barely Significant
← all excerpts

Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.

J Clin Immunol · 2023 · PMC10499723 · PMID 37266769

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Females ( n = 5) showed a trend towards higher increase in weight percentile with a mean of 35% [range − 41–89%] from 52% at start to 87% at end compared to males ( n = 32) with a mean of 13% [range − 49–97%] from 33% at start to 47% at end ( p = 0.18).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.